Hogan Lovells Publications

Watch: Is China isolated on data privacy?

China's approach to data protection regulation can often mystify: a history of lax enforcement, with a move, of late, towards tough data protection standards that threaten data localization ...

Hogan Lovells Publications

FSMA Implementation: FDA Launches Food Defense Plan Builder 2.0

The Food and Drug Administration (FDA) recently announced the launch of an updated version of the Food Defense Plan Builder Version 2.0 (FDPB) to help companies meet the requirements of the ...

Hogan Lovells Publications

FDA Announces Public Meeting and Docket for Comments on “A New Era of Smarter Food Safety” to Facilitate FSMA Implementation

The Food and Drug Administration (FDA) recently announced it will hold a full-day public meeting on October 21, 2019, regarding “A New Era of Smarter Food Safety.” As explained...

Hogan Lovells Publications

Proposed UAS remote identification rule at White House for review

White House doors now open to meetings with stakeholders about drone remote ID

Published Works

Antitrust Litigation 2019

Before the implementation of Directive 2014/104/EU on Antitrust Damages Actions (the Directive), some relevant case law had already been developed by the Spanish Supreme Court on many of...

Hogan Lovells Publications

Watch: The impact of China's new Foreign Investment Law on foreign investment in the TMT sector

A quiet revolution has been taking place in China, with the Foreign Investment Law (FIL) due to take effect on 1 January 2020.

Hogan Lovells Publications

Retreat or engage in a period of extraordinary suspicion?

Hogan Lovells Publications

U.S. Treasury Department issues new proposed CFIUS regulations

On 17 September 2019 the U.S. Department of the Treasury announced proposed regulations to "comprehensively implement the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA)."

Hogan Lovells Publications

FDA releases four final guidances on the 510(k) program; Special 510(k) guidance confirms new approach to eligibility and broader potential for IVDs

On 13 September 2019 the U.S. Food and Drug Administration (FDA or the agency) published four final guidance documents on the 510(k) program:

Loading data